Register
Forgot your password?

Cytomegalovirus infection in patients with acute myocardial infarction

Authors: Lebedeva А.M., Maryukhnich E.V., Аlbakova Т.M., Аlbakova R.M., Ryazankina N.B., Ryzhkova E.V.

Company: Department of Cardiology and Laboratory of Atherothrombosis of A.I. Yevdokimov Moscow State University of Medicine and Dentistry of Ministry of Health of the Russian Federation, Delegatskaya ulitsa, 20, stroenie 1, Moscow, 127473, Russian Federation

For correspondence:  Sign in or register.

Type:  Reviews


DOI: https://doi.org/10.24022/1997-3187-2018-12-2-159-166

For citation: Lebedeva А.M., Maryukhnich E.V., Аlbakova Т.M., Аlbakova R.M., Ryazankina N.B., Ryzhkova E.V. Cytomegalovirus infection in patients with acute myocardial infarction. Creative Cardiology. 2018; 12 (2): 159–66 (in Russ.). DOI: 10.24022/1997-3187-2018-12-2-159-166

Received / Accepted:  May 30, 2018 / June 09, 2018

Keywords: atherosclerosis acute myocardial infarction herpes virus cytomegalovirus endothelial function

Full text:  

 

Abstract

Progression and destabilization of atherosclerotic plaque are the main causes of the development of acute myocardial infarction. In recent years, convincing evidence has been obtained that the main reason of the progression of atherosclerosis is the chronic inflammatory reaction and the activation of immune cells within the atherosclerotic plaques. However, despite their importance, the causes of this inflammation remain largely unknown. Previously, data were obtained on the role of viral and bacterial infections in atherogenesis. However, the results of the studies were extremely contradictory. Among the likely triggers of the inflammatory reaction, a special place is allocated to the human herpes viruses and, above all, cytomegalovirus, as one of the most prevalent viruses in the population with a tendency to a chronic persistence in the human body, which correlates with the chronic inflammation in atherosclerotic plaques. In this review, we consider the data obtained by us and other researchers on cytomegalovirus activation in patients with coronary artery disease.

Acknowledgements. This work was supported by Russian Scientific Foundation, agreement #18-15-00420
Conflict of interest. The authors declare no conflict of interest.

References

  1. Libby P., Okamoto Y., Rocha V.Z., Folco E. Inflammation in atherosclerosis: transition from theory to practice. Circ. J. 2010; 74 (2): 213–20.

  2. Hartvigsen K., Chou M.-Y., Hansen L.F., Shaw P.X., Tsimikas S. et al. The role of innate immunity in atherogenesis. J. Lipid Res. 2008; 50 (Suppl.): S388–93.

  3. Grivel J.-C., Ivanova O., Pinegina N., Blank P.S., Shpektor A. et al. Activation of T lymphocytes in atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 2011; 31 (12): 2929–37.

  4. Humphrey L.L., Fu R., Buckley D.I., Freeman M., Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J. Gen. Intern. Med. 2008; 23 (12): 2079–86.

  5. Rosenfeld M.E., Campbell L.A. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb. Haemost. 2011; 106 (5): 858–67.

  6. Mayr M., Kiechl S., Willeit J., Wick G., Xu Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation. 2000; 102 (8): 833–9.

  7. Haider A.W., Wilson P.W.F., Larson M.G., Evans J.C., Michelson E.L. et al. The association of seroposi- tivity to Helicobacter pylori, Chlamydia pneumo- niae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J. Am. Coll. Cardiol. 2002; 40 (8): 1408–13.

  8. Longenecker C.T., Sullivan C., Baker J.V. Immune activation and cardiovascular disease in chronic HIV infection. Curr. Opin. HIV. AIDS. 2016; 11 (2): 216–25.

  9. Masiá M., Robledano C., Ortiz de la Tabla V., Antequera P., López N., Gutiérrez F. Increased Carotid intima-media thickness associated with antibody responses to varicella-zoster virus and cytomegalovirus in HIV-infected patients. PLoS One. 2013; 8 (5): e64327.

  10. Stassen F.R., Vega-Córdova X., Vliegen I., Bruggeman C.A. Immune activation following cytomegalovirus infection: More important than direct viral effects in cardiovascular disease? J. Clin. Virol. 2006; 35 (3): 349–53.

  11. Krebs P., Scandella E., Bolinger B., Engeler D., Miller S., Ludewig B. Chronic Immune reactivity against persisting microbial antigen in the vasculature exacerbates atherosclerotic lesion formation. Arterioscler. Thromb. Vasc. Biol. 2007; 27 (10): 2206–13.

  12. Sorlie P.D., Nieto F.J., Adam E., Folsom A.R., Shahar E., Massing M. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch. Intern. Med. 2000; 160 (13): 2027–32.

  13. Xenaki E., Hassoulas J., Apostolakis S., Sourvi- nos G., Spandidos D.A. Detection of cytomegalo- virus in atherosclerotic plaques and nonatherosclerotic arteries. Angiology. 2009; 60 (4): 504–8.

  14. Nikitskaya E.A., Grivel J.-C., Ivanova O.I., Lebedeva A.M., Shpektor A.V. et al. Detection of human herpes viruses DNA in coronary artery in patients who died in acute stage of myocardial infarction. Creative Cardiology. 2014; 4: 52–64 (in Russ.)

  15. Gredmark S., Jonasson L., Van Gosliga D., Ernerudh J., Söderberg-Nauclér C. Active cytomegalovirus replication in patients with coronary disease. Scand. Cardiovasc. J. 2007; 41 (4): 230–4.

  16. Nikitskaya E.A., Grivel J.C., Maryukhnich E.V, Lebedeva A.M., Ivanova O.I. et al. Cytomegalovirus in plasma of acute coronary syndrome patients. Acta Naturae. 2016; 8 (2): 102–7 (in Russ.).

  17. György B., Szabó T.G., Pásztó i M., Pál Z., Misják P. et al. Membrane vesicles, current state-of-the- art: Emerging role of extracellular vesicles. Cell. Mol. Life Sci. 2011; 68 (16): 2667–88.

  18. Ahmed W., Philip P.S., Tariq S., Khan G. EpsteinBarr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells. PLoS One. 2014; 9 (6): e99163.

  19. Jung C., Sörensson P., Saleh N., Arheden H., Rydén L., Pernow J. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-eleva- tion myocardial infarction. Atherosclerosis. 2012; 221 (1): 226–31.

  20. Vagida M., Arakelyan A., Lebedeva A., Grivel J.-C., Shpektor A. et al. Flow analysis of individual blood extracellular vesicles in acute coronary syndrome. Platelets. 2017; 28 (2): 165–73.

  21. Gimbrone M.A., García-Carden~a G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ. Res. 2016; 118 (4): 620–36.

  22. Manchurov V., Ryazankina N., Khmara T., Skrypnik D., Reztsov R. et al. Remote ischemic preconditioning and endothelial function in patients with acute myocardial infarction and pri- mary PCI. Am. J. Med. 2014; 127 (7): 670–3.

  23. Vasilieva E., Urazovskaya I., Skrypnik D., Shpek- tor A. Total occlusion of the infarct-related coronary artery correlates with brachial artery flow-mediated dilation in patients with ST-elevation myocardial infarction. Acute Card Care. 2009; 11 (3): 155–9.

  24. Abdel Hamid M., Bakhoum S.W., Sharaf Y., Sab- ry D., El-Gengehe A.T., Abdel-Latif, A. Circulating endothelial cells and endothelial function predict major adverse cardiac events and early adverse left ventricular remodeling in patients with ST-seg- ment elevation myocardial infarction. J. Interv. Cardiol. 2016; 29 (1): 89–98.

  25. Gombos R.B., Brown J.C., Teefy J., Gibeault R.L., Conn K.L. et al. Vascular dysfunction in young, mid-aged and aged mice with latent cytomegalo- virus infections. Am. J. Physiol. Heart Circ. Physiol. 2013; 304 (2): H183–94.

  26. Simmonds J., Fenton M., Dewar C., Ellins E., Storry C. et al. Endothelial dysfunction and cytomegalovirus replication in pediatric heart transplantation. Circulation. 2008; 117 (20): 2657–61.

  27. DuRose J.B., Li J., Chien S., Spector D.H. Infection of Vascular endothelial cells with human cytomegalovirus under fluid shear stress reveals preferential entry and spread of virus in flow condi- tions simulating atheroprone regions of the artery. J. Virol. 2012; 86 (24): 13745–55.

  28. Betjes M.G.H., de Wit E.E.A., Weimar W., Litjens N.H.R. Circulating pro-inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients. Nephrol. Dial. Transplant. 2010; 25 (11): 3640–6.

  29. Nikitskaya E., Lebedeva A., Ivanova O., Maryukhnich E., Shpektor A. et al. Cytomegalovirus productive infection is associated with acute coronary syndrome. J. Am. Heart Assoc. 2016; 5 (8): e003759.

  30. Roizman B., Whitley R.J. An inquiry into the molecular basis of HSV latency and reactivation. Annu. Rev. Microbiol. 2013; 67 (1): 355–74.

  31. Gyorkey F., Melnick J.L., Guinn G.A., Gyor- key P., DeBakey M.E. Herpesviridae in the endothelial and smooth muscle cells of the proximal aorta in arteriosclerotic patients. Exp. Mol. Pathol. 1984; 40 (3): 328–39.

  32. Yamashiroya H.M., Ghosh L., Yang R., Robert- son A.L. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am. J. Pathol. 1988; 130 (1): 71–9.

  33. Melnick J.L., Hu C., Burek J., Adam E., DeBa- key M.E. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol. 1994; 42 (2): 170–4.

  34. IbrahimA.I.,ObeidM.T.,JoumaM.J.,MoasisG.A., Al-Richane W.L. et al. Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J. Clin. Virol. 2005; 32 (1): 29–32.

  35. Shi Y., Tokunaga O. Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol. Int. 2002; 52 (1): 31–9.

  36. Radke P.W., Merkelbach-Bruse S., Dörge H., Naami A., Vogel G. et al. Direct evidence of cytomegalovirus in coronary atheromas of patients with advance coronary heart artery disease. Med. Klin. (Munich). 2001; 96 (3): 129–34.

  37. Horváth R., Cerny′ J., Benedík J., Hökl J., Jelínková I. The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J. Clin. Virol. 2000; 16 (1): 17–24.

  38. Izadi M., Zamani M.M., Sabetkish N., Abolhas- sani H., Saadat S.H. et al. The probable role of cytomegalovirus in acute myocardial infarction. Jundishapur J. Microbiol. 2014; 7 (3): e9253.

  39. Liu R., Moroi M., Yamamoto M., Kubota T., Ono T. et al. Presence and severity of chlamydia pneumoniae and cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes. Int. Heart J. 2006; 47 (4): 511–9.

  40. Ridker P.M., Hennekens C.H., Stampfer M.J., Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation. 1999; 98 (25): 2796–9.

  41. Hagiwara N., Toyoda K., Inoue T., Shimada H., Ibayashi S. et al. Lack of Association between infectious burden and carotid atherosclerosis in japanese patients. J. Stroke Cerebrovasc. Dis. 2007; 16 (4): 145–52.

  42. Virok D., Kis Z., Kari L., Barzo P., Sipka R. et al. Chlamydophila pneumoniae and Human cytomegalovirus in atherosclerotic carotid plaques – combined presence and possible interactions. Acta Microbiol. Immunol. Hung. 2006; 53 (1): 35–50.

  43. Adam E., Melnick J.L., DeBakey M.E. Cytomegalovirus infection and atherosclerosis. Cent. Eur. J. Public Health. 1997; 5 (3): 99–106.

  44. Nieto F.J., Adam E., Sorlie P., Farzadegan H., Melnick J.L. et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atheroscle- rosis. Circulation. 1996; 94 (5): 922–7.

  45. Simanek A.M., Dowd J.B., Pawelec G., Melzer D., Dutta A., Aiello A.E. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One. 2011; 6 (2): e16103.

  46. Ji Y.-N., An L., Zhan P., Chen X.-H. Cytomegalovirus infection and coronary heart disease risk: a meta-analysis. Mol. Biol. Rep. 2012; 39 (6): 6537–46.

  47. Savva G.M., Pachnio A., Kaul B., Morgan K., Huppert F.A. et al. Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell. 2013; 12 (3): 381–7.

  48. Timó teo A., Ferreira J., Paix~a o P., Aguiar C., Teles R. et al. Serologic markers for cytomegalovirus in acute coronary syndromes. Rev. Port. Cardiol. 2003; 22 (5): 619–31.

  49. Epstein S.E., Zhou Y.F., Zhu J. Potential role of cytomegalovirus in the pathogenesis of restenosis and atherosclerosis. Am. Heart J. 1999; 138 (5 Pt 2): S476–8.

  50. Al-Ghamdi A., Jiman-Fatani A.A., El-Banna H. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease. Pak. J. Pharm. Sci. 2011; 24 (2): 95–101.

  51. Adler S.P., Hur J.K., Wang J.B., Vetrovec G.W. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J. Infect. Dis. 1998; 177 (1): 209–12.

  52. Lebedeva A.M. Cytomegalovirus infection in patients with acute myocardial infarction and its influence on endothelial function: Cand. Med. Sc. Diss. Moscow; 2017 (in Russ.).

About Authors

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by